Ownership

Jeffrey V. Poulton - EVP, Chief Financial Officer at Alnylam Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: EVP, Chief Financial Officer
Stock Symbol: ALNY on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Jeffrey V. Poulton - trading volume in the past year for Alnylam Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-6.31K	100%	$243.93	-$1.54M
Net	-6.31K	-100%		-$1.54M

Holdings reported by Jeffrey V. Poulton for Alnylam Pharmaceuticals, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	47.8K	$11.9M	$248.36	Mar 3, 2025	Direct
Restricted Stock Units	1.91K	$466K	$244.11	Feb 27, 2025	Direct	Common Stock
Common Stock	57	$14.2K	$248.36	Mar 3, 2025	by Managed Account
Stock Option (right to buy)	9.8K			Mar 3, 2025	Direct	Common Stock

Transactions reported by Jeffrey V. Poulton for Alnylam Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.